HOME >> BIOLOGY >> NEWS
New placenta screening for high-risk pregnancies

Toronto, ON (April 2, 2007) -- For the first time ever, a team of Toronto researchers are using a combination of ultrasound and blood tests to screen high-risk pregnant mothers for placental damage. By completing these non-invasive tests, most high-risk mothers can be reassured that their placenta is formed and functioning properly, so they can expect a healthy pregnancy. The tests are done early enough, at 16 to 23 weeks gestation, so if results are abnormal, physicians have time to improve pregnancy outcomes. Close to 40 per cent of high-risk mothers we see in our clinic experience placental damage, says Dr. John Kingdom, Principal Investigator of the study and Maternal-Fetal Medicine Specialist at Mount Sinai Hospital. The research is among the first to look at placenta health a vital life line between mother and fetus through which nutrients, oxygen, antibodies and hormones pass.

By identifying early on if there is a potential risk of complications, we can do everything possible to ensure the safety of both the mother and fetus, says Dr. Kingdom, who is also a Professor in the Department of Obstetrics and Gynaecology at the University of Toronto. We can reassure those with normal test results that their placentas are functioning well and they can expect a healthy pregnancy and birth.

If the placenta is not functioning properly it could be a potential danger to the health of the mother and fetus. Abnormalities can lead to conditions such as preeclampsia, which is maternal high blood pressure, stillbirth or the need for a pre-term delivery.

The screening tests include: a maternal serum screening test used to detect Downs syndrome, which measures the hormone levels in the mothers blood; a uterine artery Doppler blood flow test, which checks the maternal blood flow in the placenta; and an ultrasound of the placental shape. Of the 212 high-risk women in the study, 19 delivered early due to poor fetal growth. None of these women h
'"/>

Contact: Jodi Salem
416-586-3161
University of Toronto
2-Apr-2007


Page: 1 2

Related biology news :

1. 100 percent of pregnant women have at least one kind of pesticide in their placenta
2. Robust time estimation reconciles views of the antiquity of placental mammals
3. Tumor-suppressor gene is critical for placenta development
4. Key to early diagnosis of autism may be in the placenta
5. New research links placenta praevia directly to assisted reproductive techniques
6. Discarded placentas deliver researchers promising cells similar to embryonic stem cells
7. ACMG recognizes progress made in newborn screening
8. Nearly 90 percent of babies receive recommended newborn screening tests
9. Pre-implantation genetic screening reduces both ongoing pregnancy and live birth rates in over 35s
10. Changes in chromosomal constitution of preimplantation embryos suggest caution in genetic screening
11. Noninvasive screening in early pregnancy reduces Downs births by 50 percent

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... -- The National Pharmaceutical Council (NPC) today announced that Ipsen ... as its newest member. David Cox , PhD, ... America ), will serve as his company,s representative ... to have Ipsen and Dr. Cox join NPC as ... welcome their insights in helping us identify and address ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... 28, 2017 Dr. Chris Yu ... corporation Anpac Bio-Medical Science Company , announced ... record, processing and reporting over 40,000 cases worldwide ... (CDA) liquid biopsy tests. Described ... Summit publications, Anpac Bio,s CDA medical devices and ...
(Date:3/28/2017)... , March 28, 2017 Biostage, Inc. ... company developing bioengineered organ implants to treat cancers and ... today announced that Jim McGorry, CEO of ... BioEngineering panel at the MassBio 2017 Annual ... PM ET in Cambrige, Massachussetts. The 3D Printing ...
Breaking Biology Technology:
Cached News: